Currently viewing the tag: "license"
Uncertainty about consequences of the recent decision by the European Patent Organisation’s (EPO) Opposition Division (OD) on the NGAL patent Is the ruling really vital for BioPorto … and in case it is not – why is it not so ? While we are still (after 8 weeks) sitting waiting for the EPO – OD’s […]
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard

